| Project/Area Number |
20590414
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Experimental pathology
|
|---|
| Research Institution | Hyogo College of Medicine |
|---|
Principal Investigator |
YAMADA Naoko Hyogo College of Medicine, 医学部, 講師 (10319858)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TERADA Nobuyuki 兵庫医科大学, 医学部, 教授 (50150339)
NAKASHO Keiji 兵庫医科大学, 医学部, 教授 (00217712)
OHYAMA Hideki 兵庫医科大学, 医学部, 准教授 (90280685)
YAMANEGI Koji 兵庫医科大学, 医学部, 講師 (00434944)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 腫瘍 / インターロイキン18 / 転移 / 骨肉腫 |
|---|
| Research Abstract |
IL-18 shows an anti-tumor action through activation of T cells and natural killer cells. We found another action of IL-18, i.e., the inhibition of metastasis by inducing the factor(s) in serum which suppresses the tumor cell mobility. In this study, we aimed to identify the tumor-cell migration inhibitory factor(s). We have revealed that IL-18 induces the factor(s) in not only serum but also the cell lysate of the liver and lung and that the factor(s) is a protein of molecular weight of less than 30,000 daltons. We have also found several candidates for the factor(s).
|
